tiprankstipranks
C4 Therapeutics (CCCC)
NASDAQ:CCCC
US Market

C4 Therapeutics (CCCC) Income Statement

Compare
473 Followers

C4 Therapeutics Income Statement

Last quarter (Q2 2024), C4 Therapeutics's total revenue was $15.36M, an increase of 38.75% from the same quarter last year. In Q2, C4 Therapeutics's net income was $-24.67M. See C4 Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 20.76M$ 31.10M$ 45.78M$ 33.20M$ 21.38M
Gross Profit
$ -96.95M$ 23.52M$ 42.88M$ -44.27M$ -26.28M
Operating Expenses
$ 159.79M$ 160.63M$ 127.92M$ 93.64M$ 56.83M
Depreciation and Amortization
$ 7.74M$ 7.57M$ 2.91M$ 2.84M$ 2.74M
EBITDA
$ -122.10M$ -124.28M$ -78.84M$ -62.89M$ -30.56M
Operating Income
$ -139.03M$ -129.53M$ -82.13M$ -60.45M$ -35.45M
Other Income/Expenses
$ 7.82M$ 1.36M$ -1.76M$ -6.51M$ 2.16M
Pretax Income
$ -131.21M$ -128.18M$ -83.89M$ -66.96M$ -33.30M
Net Income
$ -132.49M$ -126.50M$ -86.04M$ -66.33M$ -34.10M
Per Share Metrics
$ ―$ ―$ ―$ ―$ ―
Basic EPS
$ -2.67$ -2.59$ -1.87$ -1.54$ -0.79
Diluted EPS
$ -2.67$ -2.59$ -1.87$ -1.54$ -0.79
Weighted Average Shares Outstanding
49.64M 48.86M 46.04M 43.06M 42.99M
Weighted Average Shares Outstanding (Diluted)
49.64M 48.86M 46.04M 43.06M 42.99M
Currency in USD

C4 Therapeutics Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis